Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”

References

Page 1

	Year	Citations
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 Jacques Ferlay, Eva Steliarova‐Foucher, Joannie Lortet‐Tieulent, European Journal of Cancer	2013	5.2K
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford, Douglas F. Easton, Michael R. Stratton, The American Journal of Human Genetics	1998	3K
Risks of cancer in BRCA1-mutation carriers Daniel Ford The Lancet Cancer RiskBrca1-mutation CarriersMedicinePathologyCancer Genomics	1994	1.9K
Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality Susan M. Domchek JAMA	2010	1.4K
Racial Differences in the Use of <EMPH>BRCA1/2</EMPH> Testing Among Women With a Family History of Breast or Ovarian Cancer Katrina Armstrong JAMA	2005	428
Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of Age William C. Black, Robert F. Nease, Anna N.A. Tosteson JNCI Journal of the National Cancer Institute	1995	410
Population-based study of risk of breast cancer in carriers of BRCA2 mutation Steinunn Thorlacius, Jeffery P. Struewing, Patricia Hartage, The Lancet Brca2 MutationPopulation-based StudyBreast OncologyCancer EpidemiologyCancer Pathology	1998	347
Characterization of<i>BRCA1</i>and<i>BRCA2</i>Mutations in a Large United States Sample Sining Chen, Edwin S. Iversen, Tara M. Friebel, Journal of Clinical Oncology	2006	324
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services D. Gareth Evans, Julian Barwell, Diana Eccles, Breast Cancer Research	2014	309
Survival Analysis of Cancer Risk Reduction Strategies for <i>BRCA1/2</i> Mutation Carriers Allison W. Kurian, Bronislava M. Sigal, Sylvia K. Plevritis Journal of Clinical Oncology	2009	235

Page 1